Full-Time

Junior Controller

Confirmed live in the last 24 hours

Gordian Biotechnology

Gordian Biotechnology

11-50 employees

Biotech startup focused on age-related diseases

Biotechnology
Healthcare

Compensation Overview

$95k - $140kAnnually

Junior, Mid

San Bruno, CA, USA

Position requires onsite presence in South San Francisco, CA.

Category
Budget Analysis
Financial Accounting
Financial Controller
Financial Planning
Accounting
Required Skills
NetSuite
Quickbooks
Requirements
  • Bachelor’s degree in Accounting, Finance, or a related field;
  • 5+ years of relevant experience (biotech or startup experience a plus), including with setting up and managing financial systems; closing financials in a timely manner; conducting financial reporting; and supporting the budget vs. actuals process and supporting FP&A and strategic finance functions
  • Proficiency in accounting software (e.g., QuickBooks, NetSuite) and Excel, with a solid understanding of GAAP.
  • Exceptional Communication Skills: Able to translate complex financial insights into actionable steps for other teams.
Responsibilities
  • Own Daily Financial Operations: Manage core accounting functions, including accounts payable/receivable, bank reconciliations, and cash flow monitoring. Your accuracy and attention to detail will ensure we meet our financial obligations with precision.
  • Own Period Closes and Reporting of Actuals: You will ensure that Gordian’s books are closed in a timely manner every month, and that key financial metrics, including burn, runway, top spend categories and vendors, and other information is conveyed to our leadership team and other decision makers clearly, proactively, and efficiently.
  • Own the Gordian Financial Infrastructure: You’ll be the primary admin on and point of contact for Gordian’s financial tool stack, including Quickbooks Online, Brex, and Bill.com. You will also own or otherwise help manage tools that are directly tied into our financial infrastructure, including Gusto and Quartzy. You will also determine if and when we should upgrade our financial infrastructure (e.g. a migration from QBO to NetSuite).
  • Champion Compliance and Accuracy: Maintain GAAP-compliant financial statements, supporting month-end closes, annual audits, and tax preparations. You’ll implement internal controls that balance flexibility with accountability, ensuring financial health as we grow.
  • Lead Budgeting and Support Forecasting Initiatives: Support planning cycles by preparing budgets and variance analyses, and deliver insights that influence critical decisions. You will then use this information to work with the FP&A team to build forward-looking financial plans and budget models, to arm our leadership team with the possibilities in front of them.
  • Prioritize Proactive Problem-Solving: Look beyond the immediate task and anticipate financial challenges before they arise. Develop and refine scalable processes, identifying inefficiencies and proposing creative solutions that fit the startup scale.
  • Drive Cross-Functional Financial Collaboration: Partner with R&D, Operations, and other teams to track and manage financial project elements, becoming a financial ambassador who ensures that everyone—from scientists to executive leaders—understands how decisions impact the big picture.
  • Own and Excel at an Expanded Scope: Gordian is a small team, so you will need to take on tasks that may sit outside of the traditional Controller responsibilities, but which are related and crucial to the ongoing operations of the company. These tasks, such as managing our insurance plans and running payroll, will enable you to have a much more thorough and complete understanding of the company.
Gordian Biotechnology

Gordian Biotechnology

View

Gordian Biotechnology focuses on developing treatments for age-related diseases through drug discovery. The company uses advanced technologies to create models that accurately reflect the biological processes of aging, which helps in testing therapies in conditions similar to those in humans. This method increases the chances of success in clinical trials. Gordian Bio primarily collaborates with pharmaceutical companies, research institutions, and healthcare providers, generating revenue through partnerships and licensing agreements. Their goal is to extend healthy human lifespan by addressing the underlying causes of age-related diseases. They utilize animal models, like fruit flies, to study aging and test new therapies, which enhances the reliability of their research. The team consists of experts in gene therapy and genome engineering, and their work has been recognized at major industry conferences.

Company Stage

Seed

Total Funding

$58.4M

Headquarters

South San Francisco, California

Founded

1990

Growth & Insights
Headcount

6 month growth

17%

1 year growth

37%

2 year growth

73%
Simplify Jobs

Simplify's Take

What believers are saying

  • Gordian Bio's $60M venture capital launch provides strong financial backing, enabling rapid advancement in their research and development efforts.
  • The company's innovative platform has already demonstrated 80% predictive accuracy in proof-of-concept experiments, indicating a high potential for clinical success.
  • Their unique approach to using animal models that closely mimic human conditions could significantly streamline the drug discovery process, reducing time and costs.

What critics are saying

  • The niche focus on age-related diseases may limit market opportunities compared to broader biotech companies.
  • Reliance on animal models, despite their advanced nature, may still face ethical and regulatory challenges that could impact research progress.

What makes Gordian Biotechnology unique

  • Gordian Bio's high-throughput in vivo screening platform allows for the simultaneous testing of hundreds of gene therapies, a capability that is unique in the biotech industry.
  • Their use of 'patient avatars' like horses and monkeys, which closely mimic human biology, enhances the predictive accuracy of their drug discovery process.
  • Gordian Bio's focus on age-related diseases and leveraging advanced technologies like single-cell sequencing sets them apart from traditional drug discovery approaches.

Help us improve and share your feedback! Did you find this helpful?